PubMed:20711231 / 1422-1586
Annnotations
PubMed_ArguminSci
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T9 | 0-164 | DRI_Outcome | denotes | Finally, ErbB2-amplified breast cancer cells expressing a specific Pak inhibitor showed delayed tumor formation and downregulation of Erk and Akt signaling in vivo. |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T11 | 25-38 | HP_0003002 | denotes | breast cancer |
| T12 | 25-38 | HP_0100013 | denotes | breast cancer |
| T13 | 32-38 | HP_0002664 | denotes | cancer |
| T14 | 96-101 | HP_0002664 | denotes | tumor |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 20711231-7#9#14#gene2064 | 9-14 | gene2064 | denotes | ErbB2 |
| 20711231-7#25#38#diseaseC0678222 | 25-38 | diseaseC0678222 | denotes | breast cancer |
| 9#14#gene206425#38#diseaseC0678222 | 20711231-7#9#14#gene2064 | 20711231-7#25#38#diseaseC0678222 | associated_with | ErbB2,breast cancer |
CoMAGC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 142-145 | Gene | denotes | Akt |
| E2 | 116-130 | Negative_regulation | denotes | downregulation |
| T2 | 25-38 | breast cancer | denotes | breast cancer |
| R1 | T1 | E2 | themeOf | Akt,downregulation |
| R3 | T1 | T2 | CGE-decreased | Akt,breast cancer |
| R4 | T1 | T2 | CCS-cancerTOnormal | Akt,breast cancer |
| R5 | T1 | T2 | PT-observation | Akt,breast cancer |
| R3 | T1 | T2 | IGE-unidentifiable | Akt,breast cancer |